Vettori erpetici ricombinanti in strategie di vaccinazione prime-boosting per aumentare l'immunogenicità e l'efficacia protettiva di BCG Recombinant Herpes simplex-based vectors in prime-boosting vaccination strategies in order to increase the immunogenicity and the protecting effectiveness of BCG

Viral vector expressing Tat as an immunomodulatory molecule represents a new vaccine strategy for opportunistic infections

Sviluppo di vettori basati sul virus dell’Herpes simplex di tipo 1 come modello vaccinale contro Mycobacterium tuberculosis Development of vectors based on Herpes simplex virus type 1 as a vaccine model against Mycobacterium tuberculosis

Preparation of non-replicating HSV-1 viral vectors expressing HIV Tat and/or displaying other HIV proteins for systemic and mucosal immunization as an anti-HIV vaccination approach

HSV recombinant vectors expressing the HIV-1 antigens to be used as mice efficacy model to select vaccine candidates

Development of herpes simplex virus type 1 based amplicon vector as vaccines models

Herpetic vector inhibiting angiogenesis and inducing cell suicide in glioma

Herpetic vectors inhibiting angiogenesis and Inducing cell suicide in gliomas